Table 2 Clinical characteristics of patients.

From: Retrospective unbiased plasma lipidomic of progressive multiple sclerosis patients-identifies lipids discriminating those with faster clinical deterioration

  

PPMS

PPMS

PPMS-NP

PPMS-P

Baseline

1-Y FU

Baseline

1-Y FU

Baseline

1-Y FU

EDSS median

4.0

(1.5–6)

4.0

(2–6)

4.0

(1.5–6)

4.0

(2–6)

4.0

(2–6)

6.0*

(2.5–6)

9-HPT dominant hand, seconds

31.5

(19.1–62.0)

34.6

(17.6–86.8)

31.7

(20.7–62.0)

37.1

(17.6–86.8)

31.3

(19.1–62.0)

31.0

(18.2–43.4)

9-HPT non-dominant hand, seconds

35.9

(21.0–82.8)

37.3

(21.4–143.1)

30.2

(21.0–40.3)

31.8

(21.4–43.5)

41.5

(24.9–82.8)

43.35

(25.0–143.1)

25-FWT, seconds

7.0

(3.9–12.4)

7.2

(4.2–12.2)

6.8

(4.3–10.7)

6.7

(4.2–10.1)

7.3

(3.9–12.4)

7.7

(4.5–12.2)

  1. Statistically significant difference between groups (p < 0.05) is highlighted in bold.
  2. 1-Y FU = 1-year follow-up; EDSS = Expanded Disability Status Scale; 9-HPT = 9-Hole Peg Test; 25-FWT = 25-Foot Walking Test. Unless specified all values are express as mean (range).
  3. *p < 0.05, Wilcoxon signed rank test for paired samples.
Back to article page